CAR-T Cells in the Treatment of Malignant Hematological Tumors

Clinical trial NCT05619861 · UNKNOWN

Trial details

NCT number: NCT05619861
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymphoma, B-Cell Leukemia, B-cell Leukemia, T-Cell Multiple Myeloma

Start date: 2020-04-27
Primary completion: 2023-01-26
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.